// App-Quantinova.ai

4847 : Optimizing the combination of the CDK4/6 inhibitor palbociclib and paclitaxel using cell cycle analysis

Researchers

Presenter

  • Jade A. Spencer

Principal Investigators

  • Amanda D. Race

  • Patricia A. Cooper

  • Steven D. Shnyder

  • Paul M. Loadman

  • Christopher J. Twelves

Medical Centers

  • University of Bradford, Bradford, United Kingdom.

  • St. James`s Institute of Oncology and University of Leeds, Leeds, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cyclin-dependent kinase 4

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Palbociclib

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved